research use only
#retatrutide 2026-04-07
Tuesday19 messages5 participantstimes are UTC
Highlights from this day
- drawup_dee — the honest position is this has less human evidence behind it than anything else discussed here 16:41
- swab_dry_first — how do people square the research use only framing with logging their own use stepping in 7.5 increments instead of doubling is the only thing i would change if i… 17:29
- swab_dry_first — TRIUMPH is the phase 3 programme, thats the name to search rather than the molecule, someone check my working 18:16
- patent_2026 — the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial 18:19
held mine ages
triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history
is TRIUMPH the phase 3 programme
[edited]my resting rate went up 2 bpm in the first month and came back most of the way by month 8
triple agonist meaning GLP-1, GIP and glucagon, have i got that right
did anyone come off because of the heart rate
the honest position is this has less human evidence behind it than anything else discussed here
why does everyone insist on smaller steps here than on the other two
how do people square the research use only framing with logging their own use
stepping in 7.5 increments instead of doubling is the only thing i would change if i started again
phase 2 was still trending at the end which is why the phase 3 readout matters more than usual
low and slow
back after 12 months, has anything actually been published since
TRIUMPH is the phase 3 programme, thats the name to search rather than the molecule, someone check my working
mine went up too
GI was about the same as tirzepatide for me, the difference was how fast it arrived
the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial
🧊5📉5
watching my heart rate
glucagon is the new bit